Heidelberg Pharma AG (HPHA.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap134.41M
Enterprise Value120.59M
P/E Ratio-3.17
PEG Ratio0.07
Price/Sales Ratio10.19
Price/Book Ratio-4.72
Enterprise/Revenue8.09
Enterprise/EBITDA-2.85

Fiscal Year

Fiscal YearNovember 30, 2025
Most Recent QuarterAugust 31, 2026

Profitability

Profit Margin-3.21
Operating Margin-3.31
AD

Management Effectiveness

Return On Assets-0.7
Return On Equity2.01

Income Statement

Revenue1.46M
Revenue/Share0.21
Gross Profit-1.19M
EBITDA-44.63M
Net Income-42.28M
Diluted EPS-0.91

Balance Sheet

Total Cash19.84M
Total Cash/Share0.44
Total Debt298,958
Total Debt/Equity-0.02
Current Ratio4.24
Book Value Per Share-0.43

Price History

52-Week Change-30
52-Week High3.34
52-Week Low1.98
Moving Average 50 Days2.44
Moving Average 200 Days2.7

Statistics

Average Volume3,487
Shares Outstanding46.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJuly 18, 2014
AD